• Co-Diagnostics entered an exclusive distribution agreement with its longstanding Mexico partner for the Co-Dx PCR point-of-care platform, including PCR Pro instrument and test kits.
• Deal extends the existing Mexico distribution arrangement by five years, supporting a planned market launch pending regulatory authorizations.
• Mexico partner generated more than USD 18 million in revenue for Co-Diagnostics since 2020 from Logix Smart PCR tests and lab equipment.
• Prior relationship supported rollout of the Logix Smart COVID-19 PCR test, which exceeded 50% of Mexico’s COVID-19 tests through 2021.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606110900PR_NEWS_USPR_____LA81299) on June 11, 2026, and is solely responsible for the information contained therein.